EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Non-Apoptotic Programmed Cell Death: From Ultrastructural Characterization to Emerging Therapeutic Opportunities

Philip Steiner iD, Lena Wiesbauer, Hubert H Kerschbaum iD, Susanna Zierler iD

Cells · 2026

DOI: 10.3390/cells15020111 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Philip Steiner und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmacology, Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 196 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Distinct forms of non-apoptotic programmed cell death (PCD) play a central role in human and animal health and their signaling cascades provide pharmacological targets for therapeutic interventions. Non-apoptotic modalities of programmed cell death include well characterized forms, such as ferroptosis, necroptosis, pyroptosis, autophagy, paraptosis, as well as newly characterized varieties, such as cuproptosis, disulfidptosis, and erebosis. Each pathway exhibits unique molecular signaling signatures, ultrastructural characteristics, and functional outcomes that distinguish them from classical apoptosis. While pharmacological targets in the signaling cascade are promising objectives for overcoming apoptosis resistance in cancer therapy, inhibition of cell death in the myocardium or nervous system is critical for cytoprotection. This review provides detailed characterization and schematic visualization of cellular and subcellular hallmarks for each non-apoptotic PCD modality, facilitating their morphological identification. Understanding these diverse pathways is crucial for developing innovative therapeutic interventions in cancer, neurodegeneration, and inflammatory diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HumansAnimalsCuproptosisDisulfidptosisAutophagyFerroptosisNecroptosisParaptosisApoptosisNeoplasmsRegulated Cell DeathSignal TransductionNeurodegenerative DiseasesPyroptosis

Stichwörter der Autor:innen

autophagyautosiscancercaspase-independent cell deathferroptosisneurodegenerative diseasesnon-apoptotic cell deathprogrammed cell deathregulated cell deathultrastructure

Autor:innen und Institutionen

  • Institute of Pharmacology, Faculty of Medicine, Johannes Kepler University Linz, 4020 Linz, Austria.
  • Department of Biosciences and Medical Biology, Paris Lodron University Salzburg, 5020 Salzburg, Austria.
  • Walther Straub Institute of Pharmacology and Toxicology, Ludwig-Maximilians-Universität München, 80336 Munich, Germany.
  • Clinical Research Institute for Inflammation Medicine, Johannes Kepler University Linz, 4020 Linz, Austria.

ORCID-Profile: Philip Steiner, Hubert H Kerschbaum, Susanna Zierler

Zitieren

APA

Steiner, P., Wiesbauer, L., Kerschbaum, H. H., & Zierler, S. (2026). Non-Apoptotic Programmed Cell Death: From Ultrastructural Characterization to Emerging Therapeutic Opportunities. Cells. https://doi.org/10.3390/cells15020111

Vancouver

Steiner P, Wiesbauer L, Kerschbaum HH, Zierler S. Non-Apoptotic Programmed Cell Death: From Ultrastructural Characterization to Emerging Therapeutic Opportunities. Cells. 2026. doi:10.3390/cells15020111

BibTeX
@article{Steiner2026,
  author = {Steiner, Philip and Wiesbauer, Lena and Kerschbaum, Hubert H and Zierler, Susanna},
  title = {Non-Apoptotic Programmed Cell Death: From Ultrastructural Characterization to Emerging Therapeutic Opportunities},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15020111}
}
Kostenlos starten →